Côte d'Ivoire vs Yemen: Treatment success rate for patients treated for MDR-TB
Côte d'Ivoire
75.0%
in 2022
Yemen
75.0%
in 2022
Côte d'Ivoire rank
70th
Yemen rank
70th
Treatment success rate for patients treated for MDR-TB over time
- Côte d'Ivoire
- Yemen
How they compare
Côte d'Ivoire currently reports 75.0% against 75.0% in Yemen, a difference of 0.0%.
The two have swapped places 5 times across 10 shared years of data; in 2013 it was Côte d'Ivoire ahead.
Côte d'Ivoire ranks 70th and Yemen ranks 70th of 163 countries.
Côte d'Ivoire has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.4% | 72.7% | 4.7% | Côte d'Ivoire |
| 2020s | 76.0% | 73.3% | 2.7% | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Côte d'Ivoire or Yemen?
- Côte d'Ivoire, at 75.0% against 75.0% in Yemen as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Côte d'Ivoire and Yemen?
- 0.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Yemen?
- 10 years are reported by both, from 2013 to 2022.
- How do Côte d'Ivoire and Yemen rank globally for treatment success rate for patients treated for mdr-tb?
- Côte d'Ivoire ranks 70th and Yemen ranks 70th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.